loading...| Preferred Name |
Hydrocortisone Valerate |
|
| Synonyms |
HYDROCORTISONE VALERATE 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-Valerate Hydrocortisone Valerate Westcort |
|
| Definitions |
The valerate salt form of hydrocortisone, a synthetic glucocorticoid receptor agonist with antiinflammatory, antipruritic and vasoconstrictive effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2. Lack of phospholipase A2 prevents the release of arachidonic acid, precursor for inflammatory mediator prostaglandins and leukotrienes, from the cell membrane. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48024 |
|
| CAS_Registry |
57524-89-7 |
|
| CHEBI_ID |
CHEBI:50865 |
|
| Chemical_Formula |
C26H38O6 |
|
| code |
C48024 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
The valerate salt form of hydrocortisone, a synthetic glucocorticoid receptor agonist with antiinflammatory, antipruritic and vasoconstrictive effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2. Lack of phospholipase A2 prevents the release of arachidonic acid, precursor for inflammatory mediator prostaglandins and leukotrienes, from the cell membrane. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production. |
|
| FDA_UNII_Code |
68717P8FUZ |
|
| FULL_SYN |
HYDROCORTISONE VALERATE 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-Valerate Hydrocortisone Valerate Westcort |
|
| label |
Hydrocortisone Valerate |
|
| Legacy Concept Name |
Hydrocortisone_Valerate |
|
| Preferred_Name |
Hydrocortisone Valerate |
|
| prefixIRI |
Thesaurus:C48024 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0063079 |
|
| subClassOf |